View in EDS

Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Immunogenicity of the COVID-19 BNT162b2 vaccine in adolescents and young adults with cystic fibrosis.
Authors: Michos, Athanasios1 (AUTHOR) amichos@med.uoa.gr, Filippatos, Filippos1 (AUTHOR), Tatsi, Elizabeth-Barbara2 (AUTHOR), Dellis, Charilaos1 (AUTHOR), Efthymiou, Vasiliki2 (AUTHOR), Zarkada, Ioanna3 (AUTHOR), Troupi, Evgenia3 (AUTHOR), Syriopoulou, Vasiliki1 (AUTHOR), Loukou, Ioanna3 (AUTHOR)
Source: Journal of Cystic Fibrosis. May2022, Vol. 21 Issue 3, pe184-e187. 4p.
Database: Academic Search Ultimate
Description
ISSN:15691993
DOI:10.1016/j.jcf.2022.04.004